Is risperidone better than Abilify for OCD? A clinical comparison of augmentation strategies
•
5 min read
According to one recent clinical trial, aripiprazole showed a higher efficacy compared to risperidone for patients with treatment-resistant obsessive-compulsive disorder (OCD) when used as an augmentation therapy. The question of whether risperidone is better than Abilify (aripiprazole) for OCD, or vice versa, has become a key consideration for clinicians and patients seeking to improve treatment outcomes when initial therapies fail.